Rapamycin Exacerbates Staphylococcus aureus Pneumonia by Inhibiting mTOR-RPS6 in Macrophages

Rapamycin Exacerbates Staphylococcus aureus Pneumonia by Inhibiting mTOR-RPS6 in Macrophages

Fang-Yi Yu,&ast; Kua Zheng,&ast; Yin-Fang Wu,&ast; Shen-Wei Gao, Qing-Yu Weng, Chen Zhu, Yan-Ping Wu, Miao Li, Zhong-Nan Qin, Jia-Fei Lou, Zhi-Hua Chen, Song-Min Ying, Hua-Hao Shen, Wen Li Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical...

Full description

Bibliographic Details
Main Authors:	Yu FY, Zheng K, Wu YF, Gao SW, Weng QY, Zhu C, Wu YP, Li M, Qin ZN, Lou JF, Chen ZH, Ying SM, Shen HH, Li W
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-11-01
Series:	Journal of Inflammation Research
Subjects:	staphylococcus aureus pneumonia macrophage rapamycin mtor- ribosomal protein s6 signaling pathway
Online Access:	https://www.dovepress.com/rapamycin-exacerbates-staphylococcus-aureus-pneumonia-by-inhibiting-mt-peer-reviewed-fulltext-article-JIR

Similar Items

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy
by: Wei Zhao, et al.
Published: (2023-06-01)

Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and mTOR/ P70S6K/4EBP1 Signaling
by: Juan Jin, et al.
Published: (2018-07-01)

Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
by: Belinda Seto
Published: (2012-12-01)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
by: Luise Spormann, et al.
Published: (2020-07-01)

Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
by: Vincenzo Sorrenti, et al.
Published: (2022-07-01)

Role for Target of Rapamycin (mTOR) Signal Pathway in Regulating Neuronal Injury after Intracerebral Hemorrhage
by: Jie-Ping Wang, et al.
Published: (2017-01-01)

Involvement of Target of Rapamycin (TOR) Signaling in the Regulation of Crosstalk between Ribosomal Protein Small Subunit 6 Kinase-1 (RPS6K-1) and Ribosomal Proteins
by: Achala Bakshi, et al.
Published: (2023-01-01)

mTOR inhibition: a promise for a young heart.
by: Stêfany Bruno De Assis Cau, et al.
Published: (2012-02-01)

The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01)

Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury
by: Wang Xiaoping, et al.
Published: (2016-01-01)

A New Hypothesis Describing the Pathogenesis of Oral Mucosal Injury Associated with the Mammalian Target of Rapamycin (mTOR) Inhibitors
by: Stephen T. Sonis, et al.
Published: (2023-12-01)

The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway
by: Lei Liu, et al.
Published: (2018-10-01)

mTOR Inhibition via Low-Dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve?
by: E. Scott Sills, et al.
Published: (2023-07-01)

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin
by: Slingluff Craig L, et al.
Published: (2005-10-01)

Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2022-01-01)

mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation in vitro and in vivo
by: Sijia Chen, et al.
Published: (2020-02-01)

Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01)

Rapamycin Attenuates High Glucose-Induced Inflammation Through Modulation of mTOR/NF-κB Pathways in Macrophages
by: Jiezhi Dai, et al.
Published: (2019-10-01)

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
by: Aigli G. Vakrakou, et al.
Published: (2022-07-01)

Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo
by: Linyan Zhou, et al.
Published: (2017-08-01)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
by: James T. Murray, et al.
Published: (2018-05-01)

mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models
by: Lucia Lisi, et al.
Published: (2023-06-01)

Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases
by: Michael Wong
Published: (2014-04-01)

HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway
by: Haowei Wang, et al.
Published: (2022-12-01)

Telomerase and mTOR in the brain: the mitochondria connection
by: Satomi Miwa, et al.
Published: (2017-01-01)

Modulation of mTOR Signaling in Cardiovascular Disease to Target Acute and Chronic Inflammation
by: Madlen Kaldirim, et al.
Published: (2022-06-01)

Inhibition of mTOR prevents ROS production initiated by ethidium bromide-induced mitochondrial DNA depletion.
by: Timothy eNacarelli, et al.
Published: (2014-07-01)

Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats
by: Dai QD, et al.
Published: (2018-12-01)

Dose-dependent Effects of mTOR Inhibition on Weight and Mitochondrial Disease in Mice
by: Simon C Johnson, et al.
Published: (2015-07-01)

Tri-ortho-cresyl phosphate induces hepatic steatosis by mTOR activation and ER stress induction
by: Jing Li, et al.
Published: (2024-02-01)

In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules
by: Serena Vittorio, et al.
Published: (2021-02-01)

Metformin induces degradation of mTOR protein in breast cancer cells
by: Mohamed Alalem, et al.
Published: (2016-11-01)

Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line
by: Francesca Pagani, et al.
Published: (2023-02-01)

Recent advances and limitations of mTOR inhibitors in the treatment of cancer
by: Eunus S. Ali, et al.
Published: (2022-09-01)

Short‐term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone‐induced polycystic ovary syndrome mice
by: Zaixin Guo, et al.
Published: (2021-05-01)

Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review
by: Qian Wu, et al.
Published: (2023-01-01)

PREDICTION OF THE COURSE OF OSTEOARTHROSIS FROM mTOR (MAMMALIAN TARGET OF RAPAMYCIN) GENE EXPRESSION
by: E V Chetina, et al.
Published: (2012-02-01)

Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer
by: Suhail Ahmad Mir, et al.
Published: (2023-07-01)

The mTOR inhibitor rapamycin suppresses trigeminal neuropathic pain and p-MKK4/p-p38 mitogen-activated protein kinase-mediated microglial activation in the trigeminal nucleus caudalis of mice with infraorbital nerve injury
by: Ji-Hee Yeo, et al.
Published: (2023-04-01)

Effects of mTOR on neurological deficits after transient global ischemia
by: Xing Jihong, et al.
Published: (2017-04-01)